WeVote
Log In

Bill

Bill

HD 5614

An Act for long-term coverage of gender affirming care medications

194th Legislature (2025-2026) Introduced by Sam Montaño

Massachusetts bill requires health insurers to provide continuous long-term coverage for gender-affirming care medications without arbitrary time limits or repeated authorization denials.

Referred to the committee on House Rules
0
WeVote Research Nonpartisan
Bill Summary · HD 5614

Legislative bill overview

HD 5614 proposes to establish long-term insurance coverage requirements for gender-affirming care medications in Massachusetts. The bill would mandate that health insurance plans provide sustained pharmaceutical treatment for individuals undergoing gender transition, preventing coverage gaps or denials based on duration of treatment.

Why is this important

Individuals requiring hormone therapy and related medications for gender affirmation currently face inconsistent coverage across insurers, with some plans imposing time limits or requiring repeated authorization reviews. This bill addresses access and affordability for a vulnerable population while raising questions about insurance regulation, medical coverage standards, and state healthcare policy costs.

Potential points of contention

  • Insurance cost and mandate scope: Opponents may argue that broad medication coverage mandates increase premiums for all enrollees; supporters contend preventive and maintenance medications reduce overall healthcare costs
  • Medical necessity standards: Disagreement exists over whether coverage should require ongoing medical supervision/documentation or be automatically continued once initiated, affecting oversight and appropriate use
  • Scope of "gender-affirming care medications": Unclear which specific medications, dosages, and treatment protocols would qualify, potentially creating implementation and coverage consistency challenges across different insurers

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.